Newer anti-HIV drugs safest, most effective during pregnancy
National Institutes of Health (NIH) sent this bulletin at 03/11/2020 10:30 AM EDTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
03/11/2020 10:30 AM EDT
Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.